Sacyr S.A. buy krebskrebs
Start price
17.05.20
/
50%
€1.55
Target price
04.11.21
€1.92
Performance (%)
45.99%
End price
05.11.21
€2.27
Summary
This prediction ended on 05.11.21 with a price of €2.27. The BUY prediction by krebskrebs for Sacyr S.A. saw massive gains of 45.99%. Dividends of €0.066 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sacyr S.A. | 4.236% | 4.236% | 67.245% | 55.444% |
| iShares Core DAX® | 3,01 % | 1,44 % | 22,85 % | 50,83 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % | 37,06 % | 80,37 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % | 53,86 % | 60,40 % |
| iShares S&P 500 | 2,38 % | 0,24 % | 29,01 % | 59,98 % |
Comments by krebskrebs for this prediction
In the thread Sacyr S.A. diskutieren
In the thread Trading Sacyr S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten